Generic Emcure stole COVID-19 vaccine trade secrets, lawsuit claims

US pharma company HDT Bio has accused Emcure Pharmaceuticals of the “blatant theft” of its COVID-19 vaccine technology in a new lawsuit.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Emcure says court should dismiss COVID vaccine secrets suit

17 May 2022 Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.

Big Pharma

Arbutus, Genevant sue Moderna over COVID-19 vaccine tech

1 March 2022 Arbutus Biopharma and Genevant Sciences are jointly suing Moderna over royalties from the sales of its COVID-19 vaccine, which allegedly uses their tech for a drug-delivery system without authorisation.

Americas

Amgen takes on Emcure over Sensipar generic

10 September 2018 Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar.

More on this story

Big Pharma

Emcure says court should dismiss COVID vaccine secrets suit

17 May 2022 Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.

Big Pharma

Arbutus, Genevant sue Moderna over COVID-19 vaccine tech

Americas

Amgen takes on Emcure over Sensipar generic

10 September 2018 Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar.

More on this story

Big Pharma

Emcure says court should dismiss COVID vaccine secrets suit

17 May 2022 Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.

Big Pharma

Arbutus, Genevant sue Moderna over COVID-19 vaccine tech

Americas

Amgen takes on Emcure over Sensipar generic

10 September 2018 Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar.